# Tyrosine for Methamphetamine Dependence - 1

> **NCT00000322** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 89 (—)

## Conditions studied

- Amphetamine-Related Disorders

## Interventions

- **BEHAVIORAL:** Tyrosine

## Key facts

- **NCT ID:** NCT00000322
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** —
- **Final completion:** 2001-12
- **Target enrollment:** 89 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000322, "Tyrosine for Methamphetamine Dependence - 1". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*